8 results
6-K
EX-99.1
BYSI
BeyondSpring Inc
23 Oct 18
Current report (foreign)
9:17am
neutropenia, associated mortality and the need to lower chemotherapy dose intensity to sub-optimally effective levels. In addition, these G-CSF agents cause … dose intensity, delay chemotherapy cycle timing or discontinue chemotherapy, each of which can have a negative effect on the long-term outcomes
6-K
EX-99.2
BYSI
BeyondSpring Inc
23 Oct 18
Current report (foreign)
9:17am
experience grade 3/4 neutropenia. NCCN guidelines require that patients with grade 3/4 neutropenia decrease chemotherapy dose intensity, delay
424B5
BYSI
BeyondSpring Inc
7 Feb 20
Prospectus supplement for primary offering
4:16pm
with the goal of increasing compliance and persistency with prescribed chemotherapy regimens, the potential for maintenance of relative dose intensity
- Prev
- 1
- Next